Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001662252-17-000040
Filing Date
2017-03-06
Accepted
2017-03-06 09:23:51
Documents
1
Period of Report
2017-02-06
Effectiveness Date
2017-03-06

Document Format Files

Seq Description Document Type Size
1 DEF 14C rchadef14c.htm DEF 14C 88075
  Complete submission text file 0001662252-17-000040.txt   89176
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: DEF 14C | Act: 34 | File No.: 000-54767 | Film No.: 17666631
SIC: 2834 Pharmaceutical Preparations